Skip to main content

Table 1 Patient characteristics at diagnosis according to use of antidepressants before cancer diagnosis

From: Preadmission antidepressant use and bladder cancer: a population-based cohort study of stage at diagnosis, time to surgery, and surgical outcomes

  Non-users AD users
n % n %
Total 9348 89.7 1079 10.3
Median age (IQR) (years) 72.5 66.0–79.8 74.4 67.8–82.3
Age group (years)
 18–49 224 2.4 22 2.0
 50–59 814 8.7 85 7.9
 60–69 2554 27.3 235 21.8
 70–79 3475 37.2 378 35.0
 80- 2281 24.4 3539 33.3
Sex
 Male 7036 75.3 647 60.0
 Female 2312 24.7 432 40.0
Marital status
 Married 5549 59.4 532 49.3
 Widowed 1836 19.6 320 29.7
 Divorced 1233 13.2 145 13.4
 Never married 730 7.8 82 7.6
Charlson Comorbidity Index score
 Low (0) 4703 50.3 334 31.0
 Medium (1–2) 3124 33.4 437 40.5
 High (3+) 1521 16.3 308 28.5
Alcohol-related disorders 191 2.0 68 6.3
Year of cancer diagnosis
 2005–2007 2563 27.4 271 25.1
 2008–2010 2555 27.3 283 26.2
 2011–2013 2527 27.0 314 29.1
 2014–2015 1703 18.2 211 19.6
Stage of cancer at diagnosis
 Non-muscle-invasive (pT1) 3538 37.8 423 39.2
 Muscle-invasive (pT2+) 3854 41.2 437 40.5
 Missing 1956 20.9 219 20.3
Cystectomy 2370 25.4 162 15.0
 Neoadjuvant chemotherapy 222 9.4 15 9.3
Intended curative radiation therapy 1145 12.3 114 10.6
  1. All patients (n = 10,427) were diagnosed with incident invasive bladder cancer during 2005 through 2015. AD antidepressant, IQR interquartile range